Neuroprotection and Axonal Regeneration Induced by Bone Marrow Mesenchymal Stromal Cells Depend on the Type of Transplant

Mesenchymal stromal cell (MSC) therapy to treat neurodegenerative diseases has not been as successful as expected in some preclinical studies. Because preclinical research is so diverse, it is difficult to know whether the therapeutic outcome is due to the cell type, the type of transplant or the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Norte-Muñoz, María, Lucas-Ruiz, Fernando, Gallego-Ortega, Alejandro, García-Bernal, David, Valiente-Soriano, Francisco J., de la Villa, Pedro, Vidal-Sanz, Manuel, Agudo-Barriuso, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600074/
https://www.ncbi.nlm.nih.gov/pubmed/34805178
http://dx.doi.org/10.3389/fcell.2021.772223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600074/
https://www.ncbi.nlm.nih.gov/pubmed/34805178
http://dx.doi.org/10.3389/fcell.2021.772223

Ejemplares similares